ASX:ADN Andromeda Metals (ADN) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Andromeda Metals Stock (ASX:ADN) 30 days 90 days 365 days Advanced Chart Get Andromeda Metals alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume6.96 million shsAverage VolumeN/AMarket CapitalizationA$27.41 millionP/E RatioN/ADividend Yield2.50%Price TargetN/AConsensus RatingN/A Company Overview Andromeda Metals Limited, together with its subsidiaries, operates as a mineral exploration company in Australia. It explores for halloysite, kaolin, gold, and copper deposits. The company's primary project is the Great White and Mount Hope Kaolin project located in the Eyre Peninsula in South Australia. It also holds interests in the Drummond Epithermal Gold Project located in Drummond Basin, North Queensland; and the Eyre Peninsula Gold, Eyre Kaolin Project, Camel Lake Halloysite Project, and Moonta Copper Gold Project located in South Australia. The company was formerly known as Adelaide Resources Limited and changed its name to Andromeda Metals Limited in December 2016. Andromeda Metals Limited was incorporated in 1993 and is headquartered in Adelaide, Australia. Read More Receive ADN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Andromeda Metals and its competitors with MarketBeat's FREE daily newsletter. Email Address ADN Stock News HeadlinesAndromeda Metals Reveals Top 20 Option HoldersJuly 1, 2025 | tipranks.comAndromeda Metals Issues Unquoted Equity SecuritiesJuly 1, 2025 | tipranks.comA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.July 11 at 2:00 AM | American Alternative (Ad)Andromeda Metals Releases Options Distribution ReportJuly 1, 2025 | tipranks.comAndromeda Metals Reports Successful Resolutions at General MeetingJune 30, 2025 | tipranks.comNASA shares new views of our galactic neighbor, AndromedaJune 27, 2025 | msn.comHello, neighbor! See the Andromeda galaxy like never before in stunning new image from NASA's Chandra telescope (video)June 27, 2025 | msn.comAndromeda Metals to Quote New Securities on ASXJune 26, 2025 | tipranks.comSee More Headlines ADN Stock Analysis - Frequently Asked Questions How were Andromeda Metals' earnings last quarter? Andromeda Metals Limited (ASX:ADN) released its earnings results on Tuesday, March, 13th. The company reported $0.00 EPS for the quarter. What other stocks do shareholders of Andromeda Metals own? Based on aggregate information from My MarketBeat watchlists, some other companies that Andromeda Metals investors own include Artemis Resources (ARV), AstraZeneca (AZN), Docusign (DOCU), Estee Lauder Companies (EL), Grafton Group (GFTU), HSBC (HSBA). Company Calendar Last Earnings3/13/2018Today7/11/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorBasic Materials Industry Other Industrial Metals & Mining Sub-IndustryElectrical Equipment Current SymbolASX:ADN CIKN/A Webwww.andromet.com.au Phone+61-8-82710600FaxN/AEmployees200Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-A$9.56 million Net MarginsN/A Pretax MarginN/A Return on Equity0.00% Return on Assets-3.74% Debt Debt-to-Equity Ratio0.38 Current Ratio2.26 Quick Ratio14.60 Sales & Book Value Annual SalesA$2 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow17.67 Book ValueA$0.05 per share Price / BookN/AMiscellaneous Outstanding Shares3,390,000,000Free FloatN/AMarket CapA$27.41 million OptionableNot Optionable Beta1.59 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (ASX:ADN) was last updated on 7/11/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Andromeda Metals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Andromeda Metals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
